Business Wire

Xsolla Launches Buy Button for Mobile Games to Help Developers Take Back Control of Their Revenue

7.5.2025 10:00:00 CEST | Business Wire | Press Release

Share

Xsolla, a global leader in video game commerce, today announced the launch of the Xsolla Buy Button for Mobile Games, a direct-to-consumer payment solution designed to help mobile developers keep more of what they earn by saving on traditional platform fees. This release follows a significant U.S. court ruling on April 30, 2025, prohibiting Apple from blocking external payment links or charging commissions on third-party U.S. storefronts, giving developers new opportunities to connect with players and grow revenue.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507955570/en/

(Graphic: Xsolla)

With the Buy Button for Mobile Games, game developers can embed direct payment links inside their games, leading to a browser-based checkout powered by Xsolla Web Shop and Xsolla Pay Station. This checkout supports the sale of virtual items, currencies, and bundles, delivering a seamless player experience while avoiding up to 30% in platform fees.

Developers can now create a quick-to-create external link within their video game experience on an iOS mobile device. When a player taps the link, it opens up a streamlined browser-based checkout delivering a secure, pre-authenticated, frictionless purchase experience, allowing users to purchase their favorite game in fewer clicks. In addition, mobile game developers can also gain access to catalog synchronization, loyalty tools, personalized offers, and integration options required to manage the offers provided in the external link with little to no custom development.

Key Benefits of the Xsolla Buy Button:

  • Zero Platform Commission: Reclaim up to 30% of your revenue by saving on platform fees, minus standard payment processing costs.
  • Implementation: Under the April 2025 U.S. court ruling, developers can connect external payment links in-app without platform interference.
  • Frictionless One-Tap Purchase Flow: Players can purchase specific items directly from in-game offers using autofill and one-tap methods, delivering a seamless checkout experience native to the game.
    Simplified Tax and Compliance: Xsolla is the Merchant of Record, handling global tax calculation, collection, and remittance. Third-party tax solutions are unnecessary.
  • Loyalty and Player Rewards: Boost retention and engagement with loyalty programs and personalized reward options tied to player behavior within the game experience, whether in-app or online. This feature also enables issuing prepaid gift cards and parental control integration for all purchases.
  • LiveOps Sync: Align web-based promotions with in-game events, seasonal content, and player-achieved milestones to maximize the relevancy and impact of the offers provided to players.
  • Parental Control and Gift Cards: Built-in parental control and gift cards are available worldwide.
  • Multi-Channel Commerce: Extend monetization beyond the app to the web, Discord, Telegram, and other community channels where players engage.

“This court decision is a turning point for mobile game developers in the US and around the world. The Buy Button is available today through the Xsolla Web Shop,” stated Chris Hewish, Chief Strategy Officer at Xsolla. “Developers can register through the Xsolla Publisher account, use the Instant Web Shop template, and generate links in minutes without requiring custom coding. This rollout reinforces Xsolla’s commitment to building flexible, global commerce tools empowering developers to succeed and scale their business across multiple platforms.”

This offering is a game changer by giving mobile game developers control of their monetization, the ability to build closer relationships with their players, and the confidence to grow their business with long-term sustainability without previously imposed constraints.

Web Shop Integration Guide: xsolla.pro/webshop-integration

Buy Button for Mobile Games Integration Guide: xsolla.pro/buybutton

Mobile SDK Integration Guide: xsolla.pro/mobile-sdk-guide

View Video: youtu.be/Aj6gtHw5BFQ

About Xsolla

Xsolla is a leading global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.

For more information, visit xsolla.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250507955570/en/

Contacts

Media Contact

Derrick Stembridge
Vice President of Global Public Relations, Xsolla
d.stembridge@xsolla.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye